Lipocine (LPCN) Earnings Date & Reports

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

LPCN is expected to report earnings to fall 20.37% to -43 cents per share on November 11

Q3'26

Est.

$-0.43

Q1'26

Missed

by $0.07

Q1'23

Missed

by $0.01

Q4'22

Missed

by $0.31

Q3'22

Missed

by $0.48

The last earnings report on May 07 showed earnings per share of -54 cents, missing the estimate of -46 cents. With 14.39K shares outstanding, the current market capitalization sits at 17.23M.

View a ticker or compare two or three

LPCN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days